PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -75.0% | 142 | -90.2% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 1,455 | -17.0% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 1,754 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | -20.0% | 1,754 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 1,754 | -1.1% | 0.00% | – |
| Q4 2017 | $5,000 | -16.7% | 1,773 | -5.9% | 0.00% | -100.0% |
| Q3 2017 | $6,000 | +20.0% | 1,884 | -8.9% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +400.0% | 2,068 | +222.1% | 0.00% | – |
| Q1 2017 | $1,000 | – | 642 | +330.9% | 0.00% | – |
| Q3 2016 | $0 | – | 149 | +8.0% | 0.00% | – |
| Q2 2016 | $0 | – | 138 | +45.3% | 0.00% | – |
| Q1 2016 | $0 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |